Imaging HER2-positive metastatic esophagogastric cancer with 89Zr-trastuzumab PET and 18F-FDG PET.

被引：1
|
作者：
Lumish, Melissa Amy [1 ]
Maron, Steven Brad [1 ]
Paroder, Viktoriya [1 ]
Philemond, Steven [1 ]
Donoghue, Joseph A. O' [1 ]
Schoder, Heiko [1 ]
Lewis, Jason Stuart [1 ]
Janjigian, Yelena Y. [1 ]
Pandit-Taskar, Neeta [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4068
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Imaging atherosclerotic plaque in old and hyperlipidemic rabbits using 18F-FDG and PET.
    Odaka, K
    Yoshida, K
    Tadokoro, H
    Suzuki, K
    Irie, T
    Tanada, S
    Komuro, I
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 105P - 105P
  • [32] 18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO
    Gebhart, Geraldine
    Gamez, Cristina
    Holmes, Eileen
    Robles, Javier
    Garcia, Camilo
    Cortes, Montserrat
    de Azambuja, Evandro
    Fauria, Karine
    Van Dooren, Veerle
    Aktan, Gursel
    Coccia-Portugal, Maria Antonia
    Kim, Sung-Bae
    Vuylsteke, Peter
    Cure, Herve
    Eidtmann, Holger
    Baselga, Jose
    Piccart, Martine
    Flamen, Patrick
    Di Cosimo, Serena
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) : 1862 - 1868
  • [33] HER2-positive breast cancer: Combined 18F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after preoperative chemotherapy with trastuzumab.
    Vincent, Laura
    Jankowski, Clementine
    Cortet, Marion
    Arnould, Laurent
    Ladoire, Sylvain
    Coudert, Bruno P.
    Desmoulins, Isabelle
    Charon-Barra, Celine
    Beltjens, Francoise
    Rouzier, Roman
    Reyal, Fabien
    Humbert, Olivier
    Cochet, Alexandre
    Coutant, Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Cutaneous metastatic lung cancer detected with 18F-FDG PET
    Civelek, AC
    Piotrowski, B
    Osman, MM
    Memisoglu, E
    Khayyat, N
    Reimers, HJ
    Naunheim, KS
    ANNALS OF NUCLEAR MEDICINE, 2006, 20 (02) : 147 - 149
  • [35] Diagnostic ability of brain tumors by 18F-FET PET compared to 18F-FDG PET.
    Cheon, GJ
    Ahn, SH
    Cho, YS
    Kwack, HS
    Lee, CH
    Choi, CW
    Lim, SM
    Hong, SW
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 166P - 167P
  • [36] 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
    Krause, Bernd J.
    Herrmann, Ken
    Wieder, Hinrich
    zum Bueschenfelde, Christian Meyer
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 : 89S - 96S
  • [37] Differences between squamous and adenocarcinoma of the esophagus on 18F-FDG PET.
    Maragh, MR
    Refaely, Y
    Mourtzikos, K
    Greenwald, B
    Krasna, M
    Line, BR
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 297P - 297P
  • [38] Metastatic epithelioid sarcoma revealed with 18F-FDG PET/CT imaging
    Serim, Burcu Dirlik
    Vatankulu, Betul
    Halac, Metin
    Dikici, Suleyman
    Kantarci, Fatih
    Soenmezoglu, Kerim
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2016, 55 (06): : N62 - N63
  • [39] Imaging of Metastatic Epithelioid Trophoblastic Tumor With 18F-FDG PET/CT
    Patel, Tirth
    Oldan, Jorge
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (06) : E200 - E202
  • [40] 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging
    Zhou, Min
    Wang, Chenchen
    Hu, Silong
    Zhang, Yongping
    Yao, Zhifeng
    Li, Jin
    Guo, Weijian
    Zhang, Yingjian
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (07) : 694 - 700
12345